Your session is about to expire
← Back to Search
Patients with Pancreatic Cancer Ductal Adenocarcinoma (Training) for Pancreatic Cancer (PCDC Trial)
N/A
Recruiting
Led By Ajay Goel, PhD
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights
No Placebo-Only Group
Summary
This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.
Eligible Conditions
- Pancreatic Cancer
- Pancreatic Adenocarcinoma
- Pancreatic intraepithelial neoplasia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Sensitivity
Secondary study objectives
Accuracy
Specificity
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
4Treatment groups
Experimental Treatment
Group I: Patients with Pancreatic Cancer Ductal Adenocarcinoma (Validation)Experimental Treatment1 Intervention
Individuals diagnosed with pancreatic ductal adenocarcinoma
Group II: Patients with Pancreatic Cancer Ductal Adenocarcinoma (Training)Experimental Treatment1 Intervention
Individuals diagnosed with pancreatic ductal adenocarcinoma
Group III: Individuals without Pancreatic Cancer Ductal Adenocarcinoma (Validation)Experimental Treatment1 Intervention
Individuals without pancreatic ductal adenocarcinoma
Group IV: Individuals without Pancreatic Cancer Ductal Adenocarcinoma (Training)Experimental Treatment1 Intervention
Individuals without pancreatic ductal adenocarcinoma
Find a Location
Who is running the clinical trial?
City of Hope Medical CenterLead Sponsor
598 Previous Clinical Trials
1,921,376 Total Patients Enrolled
Ajay Goel, PhDPrincipal InvestigatorCity of Hope Medical Center
9 Previous Clinical Trials
5,244 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger